Dow Jones 30 Stocks SEC Filings — January 29, 2026

30-01-2026

30-01-2026

Verizon Communications Inc. filed a Form 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This multi-item filing pertains to financial results with no specific revenue, earnings, guidance, or period-over-period comparisons detailed in the provided information. No quantitative metrics, positive or negative performance indicators, or balance sheet effects are disclosed.

30-01-2026

30-01-2026

30-01-2026

Civitas Resources, Inc. disclosed in its 8-K filing on 2026-01-30 the completion of an acquisition or disposition of assets (Item 2.01) and termination of a material definitive agreement (Item 1.02), alongside notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures/elections of directors and officers (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). While the transaction completion may realize value for target stakeholders, the delisting and changes in control introduce significant negative implications including reduced liquidity and altered governance. No financial metrics, deal values, or specific parties were disclosed.

30-01-2026

Selective Insurance Group Inc filed a Form 8-K on January 30, 2026, disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by Item 9.01 for financial statements and exhibits. No specific details on the nature, scope, or implications of the amendments or changes were provided, and no quantitative financial impacts were mentioned. This is a multi-item informational filing with no evident positive or negative metrics.

30-01-2026

Autoliv Inc filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, with no quantitative data available for analysis.

30-01-2026

Flagstar Bank, National Association filed a Form 8-K on January 30, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance were mentioned. This is a standard earnings-related disclosure with no quantified metrics provided.

30-01-2026

Mechanics Bancorp filed a Form 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or guidance details in the available summary. No positive or negative performance indicators were mentioned.

30-01-2026

DORIAN LPG LTD. filed an 8-K on January 30, 2026 (AccNo: 0001596993-26-000004), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative financial metrics are explicitly stated in the provided filing information.

30-01-2026

FIRST NORTHERN COMMUNITY BANCORP filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, balance sheet changes, or other quantitative metrics are NOT_DISCLOSED in the provided information. No positive or negative performance indicators, period-over-period comparisons, or guidance revisions are detailed.

30-01-2026

NorthEast Community Bancorp, Inc./MD/ filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008167), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This is a standard voluntary disclosure typically associated with quarterly or annual financial results announcement.

30-01-2026

LyondellBasell Industries N.V. filed a Form 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or other quantitative metrics are mentioned in the provided filing details. This represents a standard earnings announcement filing with no disclosed directional performance indicators.

30-01-2026

Chevron Corp filed an 8-K on January 30, 2026 (AccNo: 0000093410-26-000019, Size: 766 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing for financial results disclosure. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are disclosed.

• ·Event Type: Financial Results
• ·Source: us_sec
• ·Sector: not specified

30-01-2026

Winvest Group Ltd filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed. No positive or negative metrics are mentioned.

30-01-2026

AMERICAN EXPRESS CO filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a standard financial results disclosure, but no specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided filing information. All detailed financial data remains NOT_DISCLOSED.

30-01-2026

Atlantic Union Bankshares Corp filed a Form 8-K on January 30, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing represents a voluntary disclosure likely including attached materials such as a press release or investor presentation. No financial metrics, transactions, guidance, or other quantitative details are specified in the filing information provided.

30-01-2026

Immunocore Holdings plc filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed.

30-01-2026

CHOICEONE FINANCIAL SERVICES INC filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-030504, Size: 2 MB), categorized as an Officer Change event, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific details on the officer position affected, appointment or resignation, reasons for change, financial metrics, period-over-period comparisons, or quantitative data are explicitly stated in the provided filing information. Sector is not specified, and no positive or negative performance indicators are mentioned.

30-01-2026

IES Holdings, Inc. filed a Form 8-K on January 30, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing summary. No positive or negative performance details, period-over-period comparisons, or strategic updates are disclosed.

30-01-2026

Colgate-Palmolive Co filed an 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are detailed in the provided filing information. All quantitative financial metrics are NOT_DISCLOSED.

30-01-2026

Sierra Bancorp filed a Form 8-K on January 30, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or contents of any exhibits are disclosed in the filing summary. This multi-item filing provides no quantitative metrics, financial impacts, or directional information.

30-01-2026

ALX Oncology Holdings Inc filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details of the other event, financial metrics, transactions, or impacts are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons mentioned.

30-01-2026

Republic Bancorp Inc./KY/ filed an 8-K on January 30, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are mentioned in the provided filing information. This is a standard financial results disclosure with no directional performance indicators available.

30-01-2026

Amgen Inc filed an 8-K on January 30, 2026, disclosing under Item 1.02 the termination of a material definitive agreement. Item 9.01 provides financial statements and exhibits. No specific details on the agreement, parties, financial impacts, or quantitative metrics are disclosed.

30-01-2026

Oppenheimer Holdings Inc. filed a Form 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are detailed in the filing description. This appears to be a standard earnings-related disclosure without quantified metrics provided.

30-01-2026

HERC Holdings Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it was an appointment or resignation, reasons for the change (e.g., retirement, performance), internal/external status, timing, board composition impact, or any financial metrics were disclosed. This appears to be a routine governance disclosure with no quantified impacts provided.

30-01-2026

RED RIVER BANCSHARES INC filed an 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02. The filing includes financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics were disclosed in the provided filing information.

30-01-2026

GLOBAL PARTNERS LP filed a Form 8-K on January 30, 2026, reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative impacts are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure primarily for Reg FD compliance, with exhibits attached.

30-01-2026

BKV Corp filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. The filing also covers unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific parties, deal terms, financial metrics, positive or negative performance indicators, or quantitative data are disclosed in the provided filing information.

30-01-2026

AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed an 8-K on January 30, 2026, disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details regarding the nature of the amendments, events, or exhibits are provided in the filing summary. No quantitative financial metrics, impacts, or period-over-period comparisons are mentioned.

30-01-2026

Ondas Holdings Inc. filed an 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific events, transactions, financial metrics, or quantitative data are disclosed in the filing metadata. No positive or negative metrics reported.

30-01-2026

MetroCity Bankshares, Inc. filed a Form 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, or other quantitative financial metrics, period-over-period comparisons, or guidance are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data available.

30-01-2026

OptimumBank Holdings, Inc. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No specific details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling potentially significant corporate actions, but lacks quantitative data for assessment.

30-01-2026

Flowco Holdings Inc. filed an 8-K on January 30, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or quantitative data are disclosed in the provided filing information. The disclosure likely includes material nonpublic information and attached exhibits, but details are NOT_DISCLOSED.

30-01-2026

Cullen/Frost Bankers, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason, timing, or any quantitative data are disclosed in the provided filing summary.

30-01-2026

International Endeavors Corp filed a Form 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement's nature, parties, terms, or financial impacts provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

30-01-2026

Sky Century Investment, Inc. filed an 8-K on January 30, 2026, reporting material modifications to rights of security holders under Item 3.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the nature of the modifications, events, or exhibits provided. No quantitative financial metrics, impacts, or comparisons are disclosed.

30-01-2026

Caro Holdings Inc. filed an 8-K on January 30, 2026 (AccNo: 0001640334-26-000176, Size: 121 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation are disclosed. Sector is NOT_DISCLOSED.

• ·Event date: January 30, 2026
• ·Source: us_sec

30-01-2026

Cannabist Co Holdings Inc. filed an 8-K on January 30, 2026, reporting under Item 8.01 Other Events. No specific event details, financial metrics, transaction values, or other quantitative data are disclosed in the provided filing information.

30-01-2026

Tevogen Bio Holdings Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004461, size 277 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information and attached exhibits, such as a press release. No quantitative metrics, transactions, or performance data—positive, negative, or flat—are disclosed in the filing summary.

30-01-2026

PEOPLES FINANCIAL SERVICES CORP. filed an 8-K on January 30, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any quantitative metrics are disclosed.

30-01-2026

Kelly Services Inc filed a multi-item Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031768), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.01 (Changes in Control of Registrant), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, named parties, quantitative metrics, or period-over-period comparisons are disclosed in the provided filing information.

30-01-2026

Blue Foundry Bancorp filed a Form 8-K on January 30, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details regarding the matters submitted, meeting date, proposals, vote outcomes, or tallies are disclosed in the available filing summary. This represents a standard mandatory disclosure for shareholder voting results.

30-01-2026

INVO Fertility, Inc. filed a multi-item Form 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, alongside other events (Item 8.01) and exhibits (Item 9.01). While the material agreement suggests potential strategic developments, the unregistered equity sales indicate possible shareholder dilution. No specific transaction details, financial metrics, or dollar values were disclosed.

30-01-2026

Yellowstone Midco Holdings II, LLC filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, named individuals, or specific details on the events were disclosed. This multi-item filing indicates significant governance and contractual changes without disclosed positive or negative impacts.

• ·Multi-item mandatory 8-K filing covering governance changes and a material agreement.
• ·No revenue, earnings, balance sheet effects, guidance, or dollar values disclosed.
• ·Critical missing information: Specific details of the material definitive agreement, identities of departing/appointed directors/officers, nature of rights modifications or amendments, any financial exhibits content, dollar value or size of transaction, period-over-period metrics. Analysis confidence: LOW (<50% key data available).

30-01-2026

SPLASH BEVERAGE GROUP, INC. filed a Form 8-K on January 30, 2026 (AccNo: 0001731122-26-000156, Size: 187 KB), reporting under Item 3.02 regarding unregistered sales of equity securities. No quantitative details such as transaction value, share count, dollar amounts, or parties involved are disclosed in the available filing information. This is a single-item mandatory disclosure typically related to exempt equity issuances under the Securities Act.

30-01-2026

Beeline Holdings, Inc. filed an 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative financial metrics, transaction values, or performance comparisons are provided in the filing summary.

30-01-2026

Kingstone Companies, Inc. filed a Form 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing information. The filing size is 164 KB, suggesting attachments, but content details are NOT_DISCLOSED.

30-01-2026

Direct Digital Holdings, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

30-01-2026

TuHURA Biosciences, Inc./NV filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031742), under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, positive developments, or additional details such as reasons, impacts, or timelines were disclosed. This represents a material negative event with no offsetting positives mentioned.

• ·Filing size: 167 KB
• ·Sector: not specified

30-01-2026

NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP /DC/ filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, transaction size, parties, financial impacts, or metrics disclosed in the provided information. No positive or negative quantitative changes are mentioned.

30-01-2026

PEDEVCO CORP filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or compensation arrangements are provided. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

30-01-2026

Microvision, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001493152-26-004505), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, quantitative metrics, or other data explicitly stated. No positive, negative, or flat performance metrics are disclosed.

30-01-2026

NEW PEOPLES BANKSHARES INC filed an 8-K on January 30, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. This is a standard financial results disclosure for the company in the US market. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed.

30-01-2026

Pioneer Bancorp, Inc./MD filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data are disclosed in the filing summary. This represents a standard voluntary earnings-related disclosure with attached exhibits.

30-01-2026

Esquire Financial Holdings, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, timing, or financial metrics are disclosed.

30-01-2026

FIRST ADVANTAGE CORP filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-031830, Size: 150 KB), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. Sector is not specified.

30-01-2026

BCB BANCORP INC filed an 8-K on 2026-01-30 (AccNo: 0001193125-26-031836) reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a standard multi-item filing for financial results disclosure, likely including a press release or earnings exhibits. No specific revenue, earnings, margins, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information.

30-01-2026

Velocity Financial, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 8.01 other events, with Item 9.01 listing financial statements and exhibits. No specific details on the agreement, events, dollar values, financial impacts, or performance metrics are disclosed in the provided filing summary. No positive or negative metrics, period-over-period comparisons, or quantitative data are mentioned.

30-01-2026

RCI Hospitality Holdings, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the provided filing information. No quantitative financial metrics, positive or negative changes, or performance comparisons are mentioned.

30-01-2026

Dragonfly Energy Holdings Corp. filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and attaching financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, parties, or financial impacts are disclosed. This is a multi-item filing focused on a material event with no quantitative metrics provided.

30-01-2026

VYNE Therapeutics Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, parties, financial impacts, or quantitative metrics are provided in the filing summary.

30-01-2026

AXIS Capital Holdings Ltd filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are provided in the filing summary. This is a standard governance disclosure with no indicated positive or negative performance metrics.

30-01-2026

Walmart Inc. filed an 8-K on 2026-01-30 under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors or certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are disclosed. No positive or negative metrics are provided in the filing summary.

30-01-2026

CCC Intelligent Solutions Holdings Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031802, Size: 172 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material nonpublic information voluntarily to comply with Regulation FD, with exhibits attached, but no specific details, financial metrics, transactions, or events are provided in the filing summary. No quantitative data or performance metrics (positive, negative, or flat) are mentioned.

30-01-2026

USCB Financial Holdings, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed.

30-01-2026

30-01-2026

IMAC Holdings, Inc. filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or impacts provided. No positive or negative financial metrics, comparisons, or guidance changes are mentioned.

30-01-2026

IF Bancorp, Inc. filed a Form 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This multi-item filing provides disclosure of financial results but no specific metrics, comparisons, or performance details are stated in the provided information. No positive, negative, or flat metrics are disclosed.

30-01-2026

International Business Machines Corp (IBM) filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, timing, or any quantitative impacts are disclosed.

30-01-2026

Arrive AI Inc. filed an 8-K on January 30, 2026, reporting Item 1.01 Entry into a Material Definitive Agreement and Item 3.02 Unregistered Sales of Equity Securities, with Item 9.01 Financial Statements and Exhibits. No specific transaction details, dollar values, parties, strategic rationale, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

30-01-2026

NanoVibronix, Inc. filed a Form 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 3.03 material modifications to rights of security holders, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction values, financial impacts, or specific terms are disclosed in the provided filing summary.

30-01-2026

Legato Merger Corp. IV filed an 8-K on 2026-01-30 (AccNo: 0001829126-26-000821) disclosing Item 3.02 Unregistered Sales of Equity Securities, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, regulatory details, or shareholder impacts are mentioned. Sector is not specified, and no quantitative data or comparisons are provided.

30-01-2026

PennantPark Investment Corp filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction values, or impacts are disclosed in the provided filing summary.

30-01-2026

Carter Bankshares, Inc. filed an 8-K on January 30, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material nonpublic information with attached supporting documents. No specific financial metrics, transactions, or quantitative data are disclosed.

30-01-2026

Saratoga Investment Corp. filed a Form 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, terms, positive or negative impacts, or other metrics are provided in the filing summary.

30-01-2026

EQV Ventures Acquisition Corp. filed an SEC document on 2026-01-30 (AccNo: 0001213900-26-010279, Size: 48 MB) related to a Merger/Acquisition event. No specific details on parties, deal structure, valuation, financial terms, synergies, regulatory pathway, shareholder impacts, or market implications are disclosed in the provided metadata. Sector is not specified, limiting assessment of strategic rationale or sector effects.

30-01-2026

NovaBay Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, disclosing changes in its certifying accountant under Item 4.01 and other events under Item 8.01. No financial metrics, transaction values, period-over-period comparisons, or impacts are mentioned. This is a multi-item filing with no quantified positive or negative details provided.

30-01-2026

Aspire Biopharma Holdings, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004543), reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. This constitutes a multi-item mandatory disclosure with no quantitative details on transaction values, share counts, or financial impacts provided. No positive or negative metrics are disclosed.

30-01-2026

XAI Octagon Floating Rate & Alternative Income Trust filed a Form 8-K on January 30, 2026, disclosing under Item 8.01 Other Events. No specific details on the event, transaction, financial metrics, or impacts are provided. This appears to be a single-item voluntary filing with no quantitative data or period-over-period comparisons disclosed.

30-01-2026

30-01-2026

30-01-2026

urban-gro, Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, alongside Item 5.07 on submission of matters to a vote of security holders and Item 9.01 for financial statements and exhibits. No specific details on positions affected, reasons for changes, vote outcomes, or exhibit contents are disclosed. No quantitative financial metrics, performance comparisons, or directional indicators provided.

30-01-2026

Ovintiv Inc. filed a Form 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing appears to voluntarily disclose material non-public information with attached exhibits, but specific details of the disclosure, events, or metrics are not provided. No financial impacts, transactions, or performance metrics (positive, negative, or flat) are mentioned.

30-01-2026

Abacus Global Management, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001628280-26-004416, Size: 216 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific events, transactions, financial metrics, or performance data disclosed in the provided information. No positive or negative metrics are mentioned.

30-01-2026

KBS Real Estate Investment Trust III, Inc. filed a Form 8-K on January 30, 2026, disclosing information under Item 7.01 (Regulation FD Disclosure) and providing Financial Statements and Exhibits under Item 9.01. This multi-item filing appears to be a voluntary disclosure to comply with Regulation FD, with exhibits attached, but no specific events, transactions, financial metrics, or performance data are detailed in the provided filing information. No positive or negative metrics are mentioned.

30-01-2026

Safe & Green Development Corp filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No positive financial metrics, growth indicators, or offsetting developments were disclosed. This event signals significant regulatory or compliance issues impacting stock market access.